250 related articles for article (PubMed ID: 17550588)
1. Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine.
Zhang Q; Lu L; Pu L; Zhang R; Shen J; Zhu Z; Hu J; Yang Z; Chen Q; Shen W
Cardiovasc Diabetol; 2007 Jun; 6():16. PubMed ID: 17550588
[TBL] [Abstract][Full Text] [Related]
2. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
[TBL] [Abstract][Full Text] [Related]
3. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
[TBL] [Abstract][Full Text] [Related]
4. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
[TBL] [Abstract][Full Text] [Related]
5. Influence of drug-eluting stent on inflammation during restenosis in a porcine coronary model.
Ge H; Zhou Y; Hanying M; Liu L; Nie X; Wang Z; Wang F
Acta Cardiol; 2010 Feb; 65(1):31-5. PubMed ID: 20306887
[TBL] [Abstract][Full Text] [Related]
6. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
[TBL] [Abstract][Full Text] [Related]
7. Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.
Jensen LO; Maeng M; Thayssen P; Villadsen A; Krusell L; Botker HE; Pedersen KE; Aaroe J; Christiansen EH; Vesterlund T; Hansen KN; Ravkilde J; Tilsted HH; Lassen JF; Thuesen L
EuroIntervention; 2011 Jul; 7(3):323-31. PubMed ID: 21729834
[TBL] [Abstract][Full Text] [Related]
8. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.
Sera F; Awata M; Uematsu M; Kotani J; Nanto S; Nagata S
JACC Cardiovasc Interv; 2009 Oct; 2(10):989-94. PubMed ID: 19850260
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial.
Abizaid A; Costa MA; Blanchard D; Albertal M; Eltchaninoff H; Guagliumi G; Geert-Jan L; Abizaid AS; Sousa AG; Wuelfert E; Wietze L; Sousa JE; Serruys PW; Morice MC;
Eur Heart J; 2004 Jan; 25(2):107-12. PubMed ID: 14720526
[TBL] [Abstract][Full Text] [Related]
10. Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
Eshtehardi P; Cook S; Wandel S; Räber L; Wenaweser P; Togni M; Vogel R; Garachemani A; Eberli FR; Lüscher TF; Jüni P; Hess OM; Meier B; Windecker S
EuroIntervention; 2010 Sep; 6(4):467-74. PubMed ID: 20884434
[TBL] [Abstract][Full Text] [Related]
11. Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study.
Hur SH; Ako J; Shimada Y; Tsujino I; Hassan AH; Abizaid A; Shiran A; Lewis BS; Guagliumi G; Cohen SA; Honda Y; Fitzgerald PJ; Sousa JE
J Invasive Cardiol; 2008 Aug; 20(8):411-6. PubMed ID: 18688066
[TBL] [Abstract][Full Text] [Related]
12. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151
[TBL] [Abstract][Full Text] [Related]
13. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound.
Degertekin M; Regar E; Tanabe K; Lemos P; Lee CH; Smits P; de Feyter P; Bruining N; Sousa E; Abizaid A; Ligthart J; Serruys PW
Am J Cardiol; 2003 May; 91(9):1046-50. PubMed ID: 12714144
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study.
Takagi T; Yamamuro A; Tamita K; Katayama M; Morioka S
J Cardiol; 2005 Apr; 45(4):139-47. PubMed ID: 15875535
[TBL] [Abstract][Full Text] [Related]
16. Neointimal response to second-generation drug-eluting stents in diabetic patients with de-novo coronary lesions: intravascular ultrasound study.
Won H; Kang TS; Hong BK; Lee S; Jeon DW; Ryu SK; Min PK; Yoon YW; Lee BK; Kwon HM; Ko YG; Jang Y
Coron Artery Dis; 2015 May; 26(3):212-9. PubMed ID: 25426659
[TBL] [Abstract][Full Text] [Related]
17. Segmental vessel wall shear stress and neointimal formation after sirolimus-eluting stent implantation: physiological insights in a porcine coronary model.
Carter AJ; Wei W; Gibson L; Collingwood R; Tio F; Dooley J; Kopia GA
Cardiovasc Revasc Med; 2005; 6(2):58-64. PubMed ID: 16263360
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A
J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176
[TBL] [Abstract][Full Text] [Related]
19. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
